Suntrust Banks Inc. Sells 20,604 Shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Suntrust Banks Inc. decreased its position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 32.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 42,378 shares of the financial services provider’s stock after selling 20,604 shares during the quarter. Suntrust Banks Inc. owned about 0.06% of iShares Nasdaq Biotechnology ETF worth $4,086,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the company. Alliancebernstein L.P. lifted its stake in iShares Nasdaq Biotechnology ETF by 36.2% during the third quarter. Alliancebernstein L.P. now owns 737,179 shares of the financial services provider’s stock worth $89,892,000 after purchasing an additional 195,746 shares during the last quarter. Blue Fin Capital Inc. acquired a new stake in shares of iShares Nasdaq Biotechnology ETF in the 3rd quarter valued at about $609,000. Credit Suisse AG grew its stake in shares of iShares Nasdaq Biotechnology ETF by 1,228.8% in the 3rd quarter. Credit Suisse AG now owns 224,782 shares of the financial services provider’s stock valued at $27,410,000 after buying an additional 207,866 shares during the period. Nan Shan Life Insurance Co. Ltd. acquired a new stake in shares of iShares Nasdaq Biotechnology ETF in the 3rd quarter valued at about $5,365,000. Finally, Bellevue Group AG acquired a new stake in shares of iShares Nasdaq Biotechnology ETF in the 3rd quarter valued at about $3,414,000. 65.97% of the stock is currently owned by institutional investors.

NASDAQ IBB traded down $0.56 during trading hours on Monday, hitting $110.49. The company’s stock had a trading volume of 2,408,591 shares, compared to its average volume of 2,289,533. iShares Nasdaq Biotechnology ETF has a 52 week low of $89.01 and a 52 week high of $122.97.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at https://www.baseballdailydigest.com/news/2019/04/15/suntrust-banks-inc-has-4-09-million-position-in-ishares-nasdaq-biotechnology-etf-ibb.html.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Story: What type of investment options does a Roth IRA provide?

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.